by Jason Heaviland | Jul 10, 2026
This data report demonstrates the capabilities of Panome Bio’s TissueBridge™ FFPE Proteomics, showcasing comprehensive protein profiling from formalin-fixed, paraffin-embedded (FFPE) tissue. The report includes protein identification, differential protein...
by Jason Heaviland | Jun 2, 2026 | Uncategorized
Transcript featuring Gary Patti (Panome Bio) and Dipender Gill (Sequoia Genetics) DIPENDER So Gary, great to get a chance to talk again. I know we’ve had numerous really stimulating conversations about proteomics, genetics, the intersection of science, and how...
by Jason Heaviland | Apr 30, 2026
Advancing the frontier of translational proteomic insights: Focus on large scale mass spectrometry A fireside conversation for biopharma, investors, and academics about maximizing translational insights from proteomic data by capitalizing on the emergence of...
by Jason Heaviland | Oct 29, 2025
Explore Panome Bio’s in-depth proteomics data report profiling global protein expression changes in HCT-116 cells with KRAS knockout. This analysis highlights key signaling pathways and molecular alterations revealed through advanced discovery proteomics analysis,...
by ODWAdmin | Oct 1, 2025 | Uncategorized
Antibody-drug conjugate (ADC) resistance represents one of the most formidable challenges in precision oncology, with clinical failures often attributed to our limited understanding of the dynamic molecular mechanisms underlying therapeutic escape. Panome Bio’s...
